iX Biopharma Ltd.   Report issue

For profit Phase 2 Phase 3
Founded: Singapore Singapore (2008)
Status: Left NME R&D (2008)

Organization Overview

First Clinical Trial
2014
NCT02199678
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

iX Biopharma | iX Biopharma Ltd.

Active Ingredients

Drugs in Phase 3 Trials (1)

sildenafil (viagra) (1 trial)

Drugs in Phase 2 Trials (2)

ketamine (ketalar) (5 trials)

oxycodone (oxycontin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Pain (Phase 2)

Erectile Dysfunction (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 3